Table 1 Distribution of lesions in Development and Validation datasets, based on expert clinical diagnosis or histology where available
Diagnosis | Development dataset | % | UK validation dataset | % | Australian validation dataset | % |
|---|---|---|---|---|---|---|
Naevus | 293 | 69. 4% | 159 | 76. 4% | 333 | 57. 3% |
Seborrhoeic keratosis | 101 | 23. 9% | 39 | 18. 7% | 128 | 22. 0% |
Solar lentigo | 0 | 0 | 0 | 0 | 67 | 11. 5% |
Basal cell carcinoma | 0 | 0 | 0 | 0 | 22 | 3. 8% |
Melanoma | 3 | 0.7% | 2 | 1. 0% | 7 | 1. 2% |
Angiokeratoma | 0 | 0.0% | 0 | 0.0% | 6 | 1. 0% |
Dermatofibroma | 14 | 3. 3% | 6 | 2. 9% | 5 | 0.9% |
Lentigo maligna | 0 | 0.0% | 0 | 0.0% | 4 | 0.7% |
Haemangioma | 11 | 2. 6% | 2 | 1. 0% | 0 | 0.0% |
Lentigo simplex | 0 | 0.0% | 0 | 0.0% | 5 | 0.9% |
Ephilis | 0 | 0.0% | 0 | 0.0% | 3 | 0.3% |
Papilloma | 0 | 0.0% | 0 | 0.0% | 1 | 0.2% |
Total | 422 | Â | 208 | Â | 581 | Â |